Phase II Study of Consolidation Chemotherapy with Amrubicin after Concurrent Etoposide and Cisplatin plus Accelerated Hyperfractionated Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer.

Trial Profile

Phase II Study of Consolidation Chemotherapy with Amrubicin after Concurrent Etoposide and Cisplatin plus Accelerated Hyperfractionated Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Dec 2011

At a glance

  • Drugs Amrubicin (Primary) ; Cisplatin; Etoposide
  • Indications Small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top